MARKET

ENVB

ENVB

Enveric Biosciences Inc
NASDAQ
1.500
-0.045
-2.91%
After Hours: 1.500 0 0.00% 16:10 09/25 EDT
OPEN
1.522
PREV CLOSE
1.545
HIGH
1.530
LOW
1.480
VOLUME
37.58K
TURNOVER
--
52 WEEK HIGH
13.25
52 WEEK LOW
1.170
MARKET CAP
6.71M
P/E (TTM)
-0.0799
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ENVB last week (0914-0918)?
Weekly Report · 4d ago
Psychedelic: Definium’s LSD-based drug meets endpoints in GAD study
TipRanks · 09/17 13:55
Enveric receives Notice of Allowance from USPTO for application for EVM401
TipRanks · 09/15 12:20
Enveric Biosciences Receives U.S. Patent Office Notice Of Allowance For An Application Covering Novel Compounds Within Its EVM401 Series Of Drug Candidates
Benzinga · 09/15 12:06
Weekly Report: what happened at ENVB last week (0907-0911)?
Weekly Report · 09/14 09:23
Weekly Report: what happened at ENVB last week (0831-0904)?
Weekly Report · 09/07 09:21
Weekly Report: what happened at ENVB last week (0824-0828)?
Weekly Report · 08/31 09:23
Weekly Report: what happened at ENVB last week (0817-0821)?
Weekly Report · 08/24 09:23
More
About ENVB
Enveric Biosciences, Inc. is a biotechnology company. The Company is engaged in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. Leveraging its discovery and development platform, the Psybrary platform, which houses proprietary information on the use and development of existing and novel molecules for specific mental health indications, the Company seeks to develop a robust intellectual property portfolio of drug candidates. Its lead molecule, EB-003, is a neuroplastogen designed to promote neuroplasticity, without inducing hallucinations, in patients suffering from difficult-to-address mental health disorders. The Company is focused on advancing EB-003 towards clinical trials for the treatment of neuropsychiatric disorders while out-licensing other Psybrary platform drug candidates to third-party licensees and advancing non-competitive market strategies for patient care.

Webull offers Enveric Biosciences Inc stock information, including NASDAQ: ENVB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENVB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENVB stock methods without spending real money on the virtual paper trading platform.